The pathogenetic mechanisms in hepatitis C virus (HCV)-related cryoglobulinemia are sustained by the chronic lymphocyte stimulation of HCV infection, and include the synthesis of IgM rheumatoid factor ... PharmiWeb: Cryoglobulinemia Treatment Market is expected to garner a market value of US$ 496 Million in 2023 The global cryoglobulinemia treatment market is anticipated to reach a market value of US$ 496 Million in 2023 and US$ 888.26 Million by 2033, registering a CAGR of 6% during that time. The rising ...

Understanding the Context

Cryoglobulinemia Treatment Market is expected to garner a market value of US$ 496 Million in 2023 As our rare disease focus continues, Diane Dike, Ph.D. shares the challenges of being diagnosed with a rare disease and speaks with a newly diagnosed cryoglobulinemia patient. The rise in online ... PharmiWeb: Cryoglobulinemia Treatment Market is expected to value of US$ 888.26 Million 2023 to 2033 Cryoglobulinemia Treatment Market is expected to value of US$ 888.26 Million 2023 to 2033 Cryoglobulinemia is a disease caused by an abundance of a protein called cryoglobulin in the blood.

Key Insights

Cryoglobulins are proteins found in the blood stream that clump together in colder temperatures. Disease in which the immune system attacks healthy tissues by mistake, called autoimmune, increases the risk of getting cryoglobulinemia. Examples are lupus, rheumatoid arthritis and Sjogren syndrome. Cryoglobulinemia is a type of vasculitis (damage and inflammation of your blood vessels) that occurs when abnormal blood proteins called cryoglobulins clump together at cold temperatures. The nature of cryoglobulins, an overview of the clinical syndromes associated with them (cryoglobulinemia, cryoglobulinemic vasculitis), their pathogenesis, associated disorders, and prognosis are the subjects of this topic review.

Final Thoughts

In the human body, these cryoglobulins precipitate together in small- and medium-sized blood vessels causing occlusions and triggering inflammatory reactions. This leads to a range of symptoms, including joint pain, skin rashes, and kidney problems. Cryoglobulinemia is classified into three groups. Cryoglobulinemia is a pathologic condition characterized by the precipitation of circulating immunoglobulins from human serum when cooled below 4ยฐC; the immunoglobulins are reversibly soluble... Cryoglobulinemia is a rare, autoimmune vasculitis characterized by the presence of abnormal proteins called cryoglobulins in the blood. These proteins can block blood vessels and restrict blood flow to various body parts, including the skin, kidneys, and liver.

Cryoglobulinemia (CG) refers to the presence of circulating immunoglobulins in the serum that precipitate at cold temperatures (<37ยฐC) and redissolve upon rewarming. There are three main types of this condition. They are grouped based on the type of antibody that is produced: Type I cryoglobulinemia is most often related to cancer of the blood or immune systems. Types II and III are also referred to as mixed cryoglobulinemia.